Liddle Syndrome with a SCNN1A Mutation: A Case Report and Literature Review
Kidney and Blood Pressure Research · 05.09.2024 · 49 (1) · 831-838
DOI: 10.1159/000540522 ↗Kurz gefasst
Fallbericht in der Zeitschrift Kidney and Blood Pressure Research, online erschienen am 05.09.2024. Verfasst von Jiajia Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Second People's Hospital of Guiyang, Guiyang, China. Hauptthemen laut MEDLINE: Liddle Syndrome, Epithelial Sodium Channels, Mutation, Missense. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Liddle syndrome is an autosomal dominant monogenic disease that mainly manifests as early-onset hypertension, hypokalaemia and metabolic alkalosis, as well as hyporeninaemia and hypoaldosteronism. The aetiology of Liddle syndrome is missense or frameshift mutations in the SCNN1A, SCNN1B, or SCNN1G genes, which encode for the epithelial sodium channel subunits. Among these, mutations in the SCNN1A gene are very rare. Case Presentation: A Liddle syndrome case caused by a SCNN1A mutation was reported from China. A 59-year-old proband had a 21-year history of chronic hypertension. His blood pressure was poorly controlled with various antihypertensive drugs, and hypokalaemia was found 8 years ago with no definite cause. At this visit, the patient presented with excessive renal potassium excretion and decreased renin activity in the postural stimulation test; however, his aldosterone level was normal. Subsequent genetic testing identified a missense mutation in SCNN1A (c.1475G>A), which encodes for a protein with an altered amino acid at position 492 (p.Arg492Gln). The pedigree investigation found that the older brother and son of the proband also have the same mutation. The patient’s serum potassium returned to normal, and blood pressure control was significantly improved after being treated with triamterene.
Conclusion
A middle-aged patient with Liddle syndrome was diagnosed. A new point mutation in the SCNN1A gene was detected in this patient, and the pathogenicity of this mutation was predicted using AlphaFold software, expanding the genetic mutation spectrum of Liddle syndrome. Genetic testing should be improved to exclude monogenic hypertension in patients with hypertension complicated with hypokalaemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The Second People's Hospital of Guiyang, Guiyang, China.
Zitieren
APA
Tian, J., Xiang, F., Wang, L., Wu, X., Shao, L., Ma, L., & Fang, C. (2024). Liddle Syndrome with a SCNN1A Mutation: A Case Report and Literature Review. Kidney and Blood Pressure Research, 49(1), 831-838. https://doi.org/10.1159/000540522
Vancouver
Tian J, Xiang F, Wang L, Wu X, Shao L, Ma L, et al. Liddle Syndrome with a SCNN1A Mutation: A Case Report and Literature Review. Kidney and Blood Pressure Research. 2024;49(1):831-838. doi:10.1159/000540522
BibTeX
@article{Tian2024,
author = {Tian, Jiajia and Xiang, Fei and Wang, Liandi and Wu, Xueyi and Shao, Lijuan and Ma, Li and Fang, Chuwen},
title = {Liddle Syndrome with a SCNN1A Mutation: A Case Report and Literature Review},
journal = {Kidney and Blood Pressure Research},
year = {2024},
volume = {49},
number = {1},
pages = {831--838},
doi = {10.1159/000540522}
}
EUVIMED